Literature DB >> 23825736

Reconstruction of H3N2 influenza virus based virosome in-vitro.

Asghar Abdoli1, Hoorieh Soleimanjahi, Masoumeh Tavassoti Kheiri, Abbas Jamali, Hesam Sohani, Mohsen Abdoli, Hamid Reza Rahmatollahi.   

Abstract

BACKGROUND AND OBJECTIVES: Virosomes are Virus Like Particles (VLP) assembled in-vitro. Influenza virosomes maintain the cell binding and membrane fusion activity of the wild type virus but are devoid of viral genetic material or internal proteins. Influenza virosomes mimic the natural antigen presentation route of the influenza virus.
METHODS: Virosomes were prepared by membrane solubilization and reconstitution. Briefly, the Madine-Darby Canine kidney (MDCK) cell line was cultivated on microcarrier beads inoculated with influenza virus strain A/X-47 (H3N2). The culture medium was harvested and clarified. Subsequently, virus was concentrated and purified by ultrafiltration and ultracentrifugation. The purified viral membrane was dissolved by adding 375 µl of 200 mM 1, 2-dicaproyl-sn-glycero-3-phosphocholine (DCPC) in HEPES-buffered saline (HBS). Nucleocapsid was removed by ultracentrifugation. The supernatant consisting of phospholipids and glycoproteins of the influenza virus was reconstituted by removal of DCPC using overnight dialysis against Hank's Buffered Saline (HBS) solution at 4°C. After dialysis, crude virosome preparation was layered over a discontinuous sucrose gradient in order to separate non-incorporated material from the reconstituted virus membranes.
RESULTS: The virosome harvested from the boundary of the two sucrose layers successfully was identified by the Hemagglutination assay and western blotting.
CONCLUSION: Use of a dialyzable short-chain phospholipid (DCPC) is an efficient procedure for solubilization and reconstitution of influenza virus virosomes and has not caused structural changes in a major envelope glycoprotein (hemagglutinin protein) on the surface of virosome.

Entities:  

Keywords:  Influenza virus; Reconstruction; Virosomes

Year:  2013        PMID: 23825736      PMCID: PMC3696854     

Source DB:  PubMed          Journal:  Iran J Microbiol        ISSN: 2008-3289


  23 in total

Review 1.  Utility of virosomal adjuvated influenza vaccines: a review of the literature.

Authors:  R Gasparini; P Lai
Journal:  J Prev Med Hyg       Date:  2010-03

Review 2.  Liposomes and virosomes as delivery systems for antigens, nucleic acids and drugs.

Authors:  Diana Felnerova; Jean-François Viret; Reinhard Glück; Christian Moser
Journal:  Curr Opin Biotechnol       Date:  2004-12       Impact factor: 9.740

Review 3.  Eleven years of Inflexal V-a virosomal adjuvanted influenza vaccine.

Authors:  Christian Herzog; Katharina Hartmann; Valérie Künzi; Oliver Kürsteiner; Robert Mischler; Hedvika Lazar; Reinhard Glück
Journal:  Vaccine       Date:  2009-05-29       Impact factor: 3.641

Review 4.  Influenza vaccines: the virosome concept.

Authors:  Jan Wilschut
Journal:  Immunol Lett       Date:  2008-12-25       Impact factor: 3.685

5.  Preparation, properties, and applications of reconstituted influenza virus envelopes (virosomes).

Authors:  R Bron; A Ortiz; J Dijkstra; T Stegmann; J Wilschut
Journal:  Methods Enzymol       Date:  1993       Impact factor: 1.600

6.  A virosomal immunization strategy against cervical cancer and pre-malignant cervical disease.

Authors:  Laura Bungener; Arjan de Mare; Jacqueline de Vries-Idema; Peter Sehr; Ate van der Zee; Jan Wilschut; Toos Daemen
Journal:  Antivir Ther       Date:  2006

7.  Metabolism of MDCK cells during cell growth and influenza virus production in large-scale microcarrier culture.

Authors:  Y Genzel; I Behrendt; S König; H Sann; U Reichl
Journal:  Vaccine       Date:  2004-06-02       Impact factor: 3.641

8.  Development of a mammalian cell (Vero) derived candidate influenza virus vaccine.

Authors:  O Kistner; P N Barrett; W Mundt; M Reiter; S Schober-Bendixen; F Dorner
Journal:  Vaccine       Date:  1998 May-Jun       Impact factor: 3.641

9.  Reconstitution of functional influenza virus envelopes and fusion with membranes and liposomes lacking virus receptors.

Authors:  O Nussbaum; M Lapidot; A Loyter
Journal:  J Virol       Date:  1987-07       Impact factor: 5.103

10.  A comparative analysis of routine techniques: Reverse transcriptase polymerase chain reaction (RT-PCR) and five cell lines for detection of enteroviruses in stool specimens.

Authors:  F Abbasian; H Tabatabaie; M Sarijloo; S Shahmahmoodi; A Yousefi; T Saberbaghi; T Mokhtari Azad; R Nategh
Journal:  Iran J Microbiol       Date:  2011-06
View more
  3 in total

1.  The Promise and Challenge of Digital Biology.

Authors:  Mark E Minie; Ram Samudrala
Journal:  J Bioeng Biomed Sci       Date:  2013-12-04

Review 2.  Nanotechnology-based antiviral therapeutics.

Authors:  Malobika Chakravarty; Amisha Vora
Journal:  Drug Deliv Transl Res       Date:  2021-06       Impact factor: 4.617

Review 3.  Safety and potency of BIV1-CovIran inactivated vaccine candidate for SARS-CoV-2: A preclinical study.

Authors:  Asghar Abdoli; Reza Aalizadeh; Hossein Aminianfar; Zahra Kianmehr; Ali Teimoori; Ebrahim Azimi; Nabbi Emamipour; Marzieh Eghtedardoost; Vahid Siavashi; Hamidreza Jamshidi; Mohammadreza Hosseinpour; Mohammad Taqavian; Hasan Jalili
Journal:  Rev Med Virol       Date:  2021-10-26       Impact factor: 11.043

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.